3D Cell Culture Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
3D Cell Culture Market size exceeded more than USD 1.5 billion in 2022 and is projected to witness 14.3% CAGR during 2023-2032. Rising preference for efficient and affordable drug discovery methods to drive industry expansion.
The surging emphasis on developing alternatives to animal testing will influence the expansion for 3D cell cultures. In recent years, most industries are working on the development of new platforms, such as innovative human 3D tissue-engineered models for replacing animal and flask cell-culture models. The increasing usage of organs-on-a-chip (OoCs) as an alternative candidate for drug screening and cell experiments will also anchor the market growth.|
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| 3D Cell Culture Market size in 2022: | USD 1.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 - 2032 CAGR: | 14.3 |
| 2023 Value Projection: | USD 5.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No of Pages: | 150 |
| Tables, Charts & Figures: | 466 |
| Segments Covered: | Type, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls Challenges: |
|
The escalating costs associated with cell biology research may act as a significant restraint for the 3D cell culture market progress. This is mainly due to the tremendous inefficiencies incurred during the R&D activities. It has been estimated that scientists in the U.S. spend $28 billion per year on basic biomedical research that is not repeated successfully. The growing costs of biology lab equipment will also limit the rise for 3D cell cultures.
3D cell culture market from Scaffold-based segment will exceed USD 3 billion by 2032. The expansion can be attributed to the increasing dominance of scaffolds in cell therapy and drug discovery applications. The growing burden of various chronic conditions, including cardiovascular diseases and cancer will further contribute to the adoption of scaffold-based 3D cell cultures.
3D cell culture market from the cancer application segment is likely hit USD 2.3 billion by 2032. 3D systems are increasingly deployed in cancer research as they facilitate efficacy testing, safety, and fundamental research. 3D cell culture models help in replicating the natural tumor architecture to provide an external proliferating zone, as well as nutrient and progression factor distribution. Increasing application in therapeutic fields, mainly in applications involving precision medicine will fuel to the market statistics.
North America registered 46.5% of the 3D cell culture market share in 2022 on account of the rising number of universities and research organisations in the region. The growing government initiatives and funding for the development of advanced 3D culture models will also bolster the regional business scenario. For instance, in March 2023, ALS Society of Canada (ALS Canada) joined forces with Brain Canada for investing $1.4 million to support 9 projects on cutting-edge discoveries as well as treatments for amyotrophic lateral sclerosis (ALS).
Some of the prominent 3D cell culture industry players include :
By Type
By Application
By End-use
The above information is provided for the following regions and countries:
North America recorded 46.5% of the 3D cell culture industry share in 2022 on account of the rising number of universities and research organisations in the region.
Scaffold-based segment will exceed USD 3 billion by the end of 2032 due to higher adoption in cell therapy and drug discovery applications.
3D cell culture market share from the cancer application segment will reach USD 2.3 billion by the end of 2032 with increasingly deployment in cancer research to facilitate efficacy testing, safety, and fundamental research.
3D cell culture industry size reached USD 1.5 billion in 2022 and is estimated to observe 14.3% CAGR from 2023-2032 owing to the surging emphasis on developing alternatives to animal testing.